Jacob George

682 total citations · 1 hit paper
17 papers, 322 citations indexed

About

Jacob George is a scholar working on Epidemiology, Hepatology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Jacob George has authored 17 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 5 papers in Hepatology and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Jacob George's work include Liver Disease Diagnosis and Treatment (11 papers), Diet, Metabolism, and Disease (3 papers) and Liver Disease and Transplantation (2 papers). Jacob George is often cited by papers focused on Liver Disease Diagnosis and Treatment (11 papers), Diet, Metabolism, and Disease (3 papers) and Liver Disease and Transplantation (2 papers). Jacob George collaborates with scholars based in Australia, United States and Iran. Jacob George's co-authors include Cameron Gofton, Ming‐Hua Zheng, A. Ayres, S. Bowden, Ashraf Mohamadkhani, Hossein Poustchi, Stephen Locarnini, Ghodratollah Montazeri, Graham Farrell and Peter Revill and has published in prestigious journals such as Alimentary Pharmacology & Therapeutics, Current Pharmaceutical Design and Clinical Nutrition.

In The Last Decade

Jacob George

14 papers receiving 317 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MAFLD: How is it different from NAFLD?

2022 238 citations Cameron Gofton, Ming‐Hua Zheng et al. Clinical and Molecular Hepatology profile →

Peers

Jacob George

EPIDE

EDM

HEPAT

PHYSI

Cameron Gofton Australia

Evangelia Makri Greece

M.-C. Brindisi France

Valentina Peta France

Margaret LP Teng Singapore

Claudia La Mantia Italy

Marta Flisiak‐Jackiewicz Poland

Cristina Muzîca Romania

KeeSeok Lee United States

Georgios Kalopitas Greece

Cameron Gofton Australia

Jacob George

238 ×1.0

EPIDE

122 ×1.1

EDM

77 ×0.8

HEPAT

43 ×0.9

PHYSI

51 ×1.2

Citations per year, relative to Jacob George Jacob George (= 1×) peers Cameron Gofton

Countries citing papers authored by Jacob George

Since Specialization

Citations

This map shows the geographic impact of Jacob George's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob George with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob George more than expected).

Fields of papers citing papers by Jacob George

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacob George. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob George. The network helps show where Jacob George may publish in the future.

Co-authorship network of co-authors of Jacob George

This figure shows the co-authorship network connecting the top 25 collaborators of Jacob George. A scholar is included among the top collaborators of Jacob George based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacob George. Jacob George is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Khakpoor, Atefeh, Mary Eapen, Liang Lim, et al.. (2025). 106 Spatial multi-omic characterization of tumor microenvironment heterogeneity in hepatocellular carcinoma. Regular and Young Investigator Award Abstracts. A121–A122.

Crane, Harry, et al.. (2025). Global prevalence, metabolic characteristics, and outcomes of lean-MAFLD: a systematic review and meta-analysis. Hepatology International. 19(3). 607–618. 2 indexed citations

George, Jacob, et al.. (2025). The Association Between Serum Gamma‐Glutamyl Transferase and Gastrointestinal Cancer Risk: A Systematic Review and Meta‐Analysis. Cancer Medicine. 14(2). e70581–e70581. 8 indexed citations

Pan, Ziyan, Lawrence Yuen, Christopher B. Nahm, et al.. (2025). Characterisation of non-cirrhotic MAFLD-related hepatocellular carcinoma: a retrospective cohort study. Therapeutic Advances in Chronic Disease. 16. 404387978–404387978.

Clark, Paul J., Patricia C. Valery, Simone I. Strasser, et al.. (2025). Surviving Hepatitis C—Understanding Death and Survival Beyond Cure. Alimentary Pharmacology & Therapeutics. 62(6). 602–619. 1 indexed citations

Kouvari, Matina, Laura Valenzuela‐Vallejo, Ornella Verrastro, et al.. (2024). Apolipoprotein C-III in association with metabolic-dysfunction associated steatotic liver disease: A large, multicenter study. Clinical Nutrition. 43(12). 101–108.

George, Jacob, et al.. (2024). Medicinal Mishap: Severe liver injury following use of RAD-140, a selective androgen receptor modulator, for body building. Australian Prescriber. 47(1). 26–28. 2 indexed citations

Nicoll, Amanda, Jacob George, David Prince, et al.. (2024). Drug‐induced liver injury from selective androgen receptor modulators, anabolic‐androgenic steroids and bodybuilding supplements in Australia. Alimentary Pharmacology & Therapeutics. 59(8). 953–961. 3 indexed citations

Kumar, Shashi, et al.. (2024). Torsemide in Edema Associated with Chronic Kidney Disease. Journal of the Association of Physicians of India. 72(9). 27–31. 1 indexed citations

10.

Pan, Ziyan, et al.. (2024). Clinical features and mortality outcomes of patients with MASLD only compared to those with MAFLD and MASLD. Hepatology International. 18(6). 1731–1739. 4 indexed citations

11.

Prasad, P. V. Vara, et al.. (2023). Patterns of investment in agricultural research and innovation for the Global South, with a focus on sustainable agricultural intensification. Frontiers in Sustainable Food Systems. 7. 11 indexed citations

12.

Gofton, Cameron, et al.. (2022). MAFLD: How is it different from NAFLD?. Clinical and Molecular Hepatology. 29(Suppl). S17–S31. 238 indexed citations breakdown →

13.

George, Jacob, et al.. (2022). The Translation and Commercialisation of Biomarkers for Cardiovascular Disease—A Review. Frontiers in Cardiovascular Medicine. 9. 897106–897106. 2 indexed citations

14.

Lazarus, Jeffrey V., Henry E. Mark, Massimo Colombo, et al.. (2021). A sustainable development goal framework to guide multisectoral action on NAFLD through a societal approach. Alimentary Pharmacology & Therapeutics. 55(2). 234–243. 8 indexed citations

15.

Marietti, M., Chiara Saponaro, E. Buzzigoli, et al.. (2016). Adipose tissue insulin resistance is associated with macrophage activation in non-diabetic patients with non-alcoholic fatty liver disease. Digestive and Liver Disease. 48. e12–e12. 1 indexed citations

16.

Carulli, Lucia, Mauro Maurantonio, Lionel Hebbard, et al.. (2012). Classical and Innovative Insulin Sensitizing Drugs for the Prevention and Treatment of NAFLD. Current Pharmaceutical Design. 19(29). 5280–5296. 2 indexed citations

17.

Poustchi, Hossein, Ashraf Mohamadkhani, S. Bowden, et al.. (2008). Clinical significance of precore and core promoter mutations in genotype D hepatitis B‐related chronic liver disease. Journal of Viral Hepatitis. 15(10). 753–760. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact